Display Settings:

Format

Send to:

Choose Destination
    J Biol Chem. 1990 Apr 15;265(11):5960-3.

    Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor.

    Source

    Diabetes and Endocrine Research Laboratory, Mount Zion Hospital and Medical Center, San Francisco, CA 94115.

    Abstract

    In BC3H-1 cells, a model for studying the events that occur when myoblasts transform into myocytes, we observed that differentiation was associated with a 10-20-fold increase in both gene transcription and mRNA levels for myogenin, a member of the myc gene family. In contrast, the expression of the related protein MyoD1 was not influenced. This enhanced expression of myogenin was followed by morphological differentiation and increased expression of the nicotinic acetylcholine receptor, a muscle-specific gene product. Exposure of BC3H-1 cells to a 20-base myogenin antisense oligomer blocked morphological differentiation and resulted in nearly complete inhibition of acetylcholine receptor protein expression. To further study the relationship between muscle cell differentiation and myogenin gene expression, fibroblast growth factor (FGF), a known inhibitor of myogenic differentiation, was employed. FGF treatment inhibited myogenin gene transcription and BC3H-1 cell differentiation. These results demonstrate therefore that myogenin is an important regulator of skeletal muscle cell differentiation, and the expression of myogenin is under the control of FGF.

    PMID:
    1690720
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk